These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

355 related items for PubMed ID: 23901761

  • 1. Viral kinetics, shedding profile, and transmission of serotype 1 Marek's disease vaccine Rispens/CVI988 in maternal antibody-free chickens.
    Islam T, Renz KG, Walkden-Brown SW, Ralapanawe S.
    Avian Dis; 2013 Jun; 57(2 Suppl):454-63. PubMed ID: 23901761
    [Abstract] [Full Text] [Related]

  • 2. Field studies of the detection, persistence and spread of the Rispens CVI988 vaccine virus and the extent of co-infection with Marek's disease virus.
    Ralapanawe S, Renz KG, Burgess SK, Walkden-Brown SW.
    Aust Vet J; 2016 Sep; 94(9):329-37. PubMed ID: 27569836
    [Abstract] [Full Text] [Related]

  • 3. Replication kinetics and shedding of very virulent Marek's disease virus and vaccinal Rispens/CVI988 virus during single and mixed infections varying in order and interval between infections.
    Islam T, Walkden-Brown SW, Renz KG, Islam AF, Ralapanawe S.
    Vet Microbiol; 2014 Oct 10; 173(3-4):208-23. PubMed ID: 25213229
    [Abstract] [Full Text] [Related]

  • 4. Detection and differentiation of CVI988 (Rispens vaccine) from other serotype 1 Marek's disease viruses.
    Gimeno IM, Dunn JR, Cortes AL, El-Gohary Ael-G, Silva RF.
    Avian Dis; 2014 Jun 10; 58(2):232-43. PubMed ID: 25055627
    [Abstract] [Full Text] [Related]

  • 5. Influence of vaccination with CVI988/Rispens on load and replication of a very virulent Marek's disease virus strain in feathers of chickens.
    Haq K, Fear T, Ibraheem A, Abdul-Careem MF, Sharif S.
    Avian Pathol; 2012 Jun 10; 41(1):69-75. PubMed ID: 22845323
    [Abstract] [Full Text] [Related]

  • 6. Correlation of Marek's disease herpesvirus vaccine virus genome load in feather tips with protection, using an experimental challenge model.
    Baigent SJ, Smith LP, Currie RJ, Nair VK.
    Avian Pathol; 2007 Dec 10; 36(6):467-74. PubMed ID: 17994325
    [Abstract] [Full Text] [Related]

  • 7. A comparative evaluation of the protective efficacy of rMd5deltaMeq and CVI988/ Rispens against a vv+ strain of Marek's disease virus infection in a series of recombinant congenic strains of White Leghorn chickens.
    Chang S, Ding Z, Dunn JR, Lee LF, Heidari M, Song J, Ernst CW, Zhang H.
    Avian Dis; 2011 Sep 10; 55(3):384-90. PubMed ID: 22017035
    [Abstract] [Full Text] [Related]

  • 8. Vaccination-challenge interval markedly influences protection provided by Rispens CVI988 vaccine against very virulent Marek's disease virus challenge.
    Islam T, Walkden Brown SW, Renz KG, Fakhrul Islam AF, Ralapanawe S.
    Avian Pathol; 2013 Dec 10; 42(6):516-26. PubMed ID: 24098951
    [Abstract] [Full Text] [Related]

  • 9. Kinetics of Marek's disease virus (MDV) infection in broiler chickens 1: effect of varying vaccination to challenge interval on vaccinal protection and load of MDV and herpesvirus of turkey in the spleen and feather dander over time.
    Fakhrul Islam AF, Walkden-Brown SW, Groves PJ, Underwood GJ.
    Avian Pathol; 2008 Jun 10; 37(3):225-35. PubMed ID: 18568648
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Differential amplification of Marek's disease CVI988 vaccine and of wild-type isolates from organs of commercial chickens using single or duplexed probes in real-time PCR.
    Davidson I, Natour-Altoury A, Raibstein I, Dahan Y.
    Avian Pathol; 2017 Dec 10; 46(6):610-614. PubMed ID: 28532188
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effects of Rispens CVI988 vaccination followed by challenge with Marek's disease viruses of differing virulence on the replication kinetics and shedding of the vaccine and challenge viruses.
    Ralapanawe S, Walkden-Brown SW, Islam AF, Renz KG.
    Vet Microbiol; 2016 Feb 01; 183():21-9. PubMed ID: 26790931
    [Abstract] [Full Text] [Related]

  • 14. Protection provided by Rispens CVI988 vaccine against Marek's disease virus isolates of different pathotypes and early prediction of vaccine take and MD outcome.
    Ralapanawe S, Walkden-Brown SW, Renz KG, Islam AF.
    Avian Pathol; 2016 Feb 01; 45(1):26-37. PubMed ID: 26503904
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Differentiation between pathogenic serotype 1 isolates of Marek's disease virus and the Rispens CVI988 vaccine in Australia using real-time PCR and high resolution melt curve analysis.
    Renz KG, Cheetham BF, Walkden-Brown SW.
    J Virol Methods; 2013 Jan 01; 187(1):144-52. PubMed ID: 23041147
    [Abstract] [Full Text] [Related]

  • 18. Comparative evaluation of vaccine efficacy of recombinant Marek's disease virus vaccine lacking Meq oncogene in commercial chickens.
    Lee LF, Kreager KS, Arango J, Paraguassu A, Beckman B, Zhang H, Fadly A, Lupiani B, Reddy SM.
    Vaccine; 2010 Feb 03; 28(5):1294-9. PubMed ID: 19941987
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.